Globally oncology is rapidly becoming one of the major causes of death besides cardiovascular and CNS related ailments; the other two important causes for high mortality rate. As predicted by WHO global incidence of cancer between 2000 and 2020 will rise by 50%, taking the count to approx. 15 million cases. Fortunately for those diagnosed with cancer during this period, even cancer treatment will evolve along with the oncology market, creating many treatment alternatives for the patients and turnover to the tune of more than $60 billion for the marketers.

Unfortunately today, Pharma companies have to combat decreasing profits margins due to patent expiration, increased generic competition, and dearth of inventions along with global healthcare system's continuous effort to contain the cost of treatment for oncology patients. It is increasingly becoming important fore the companies to allocate available resources appropriately and identifying different market opportunities and challenges proactively. For increasing ROI and making the product's lifecycle profitable, oncology sales management must overcome key planning challenges.

marketRx has comprehensive experience in addressing these issues faced by the oncology clients and understanding the clinical and strategic challenges in commercialization of new drugs.

Our analytical tools combine field intelligence with our sales planning expertise, and data knowledge to develop deep and relevant oncology market insight to help you capture full potential of your key accounts.

marketRx's robust analytical sales force effectiveness tools have helped many of our oncology clients to address key issue related to-

• Customer profiling and Segmentation
• Market Valuation and Tracking
• Sales Force Optimization
• Sales and Marketing Performance

Benefits of working with marketRx

• Our extensive experience in oncology markets has supported several brands at different maturity stages
  • Market preparation for a new indication
  • Launch strategy for a new product
  • Uptake monitoring and message tracking for new treatment
  • Life cycle management of a mature brand
• Our methodical approach and analytical tools has supported several clients in facing different market opportunities and challenges successfully
  • Help capture untapped potential leveraging new clinical data
  • Improve yield by measuring physician / patient attitude towards new guidelines
  • Defensive strategy against a new entrant - message tracking, generic competition
  • Market protection from a competitive market launch
• Several oncology franchises with diverse portfolios have leveraged our integrated solutions in diverse therapeutic areas including
  • Cytotoxic, hormonal and targeted therapies
  • Oral and infusion/injection forms
  • Leukemia, colorectal cancer, bone metastasis, breast cancer, NSCLC-Lung